These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1607662)

  • 1. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
    Schafer R; Portnoy DA; Brassell SA; Paterson Y
    J Immunol; 1992 Jul; 149(1):53-9. PubMed ID: 1607662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
    Okamoto S; Kawabata S; Nakagawa I; Hamada S
    Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma.
    Paglia P; Arioli I; Frahm N; Chakraborty T; Colombo MP; Guzmàn CA
    Eur J Immunol; 1997 Jun; 27(6):1570-5. PubMed ID: 9209512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms.
    Weiskirch LM; Pan ZK; Paterson Y
    Clin Immunol; 2001 Mar; 98(3):346-57. PubMed ID: 11237558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
    Fuerst TR; Stover CK; de la Cruz VF
    Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
    Hu ZY; He P; Fang X; Qiu SH; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):810-4. PubMed ID: 19103120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes.
    Miller MA; Skeen MJ; Ziegler HK
    J Immunol; 1995 Nov; 155(10):4817-28. PubMed ID: 7594484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.
    Mata M; Paterson Y
    J Immunol; 1999 Aug; 163(3):1449-56. PubMed ID: 10415046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response.
    Goossens PL; Montixi C; Saron MF; Rodriguez M; Zavala F; Milon G
    Biologicals; 1995 Jun; 23(2):135-43. PubMed ID: 7546656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
    Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
    Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice.
    Onoé K; Good RA; Yamamoto K
    J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.
    Frankel FR; Hegde S; Lieberman J; Paterson Y
    J Immunol; 1995 Nov; 155(10):4775-82. PubMed ID: 7594479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
    He P; Chen H; Liu JX; Chen SY; Hu BY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):238-42. PubMed ID: 15640857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
    Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.